U.S. markets closed

Ipsen S.A. (IPSEY)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
23.92-0.40 (-1.62%)
At close: 3:34PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close24.32
Open24.35
Bid0.00 x 0
Ask0.00 x 0
Day's Range23.92 - 24.35
52 Week Range19.35 - 28.10
Volume1,150
Avg. Volume1,734
Market Cap7.992B
Beta (5Y Monthly)0.98
PE Ratio (TTM)10.78
EPS (TTM)2.22
Earnings DateN/A
Forward Dividend & Yield0.30 (1.27%)
Ex-Dividend DateMay 28, 2021
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • IPSEN SA
    Analyst Report: AbbVie Inc.AbbVie is a drug company with a strong exposure to immunology and oncology. The company's top drug, Humira, represents close to half of the company's current profits. The company was spun off from Abbott in early 2013. The recent acquisition of Allergan adds several new drugs in aesthetics and women's health.
    Rating
    Fair Value
    Economic Moat
    6 days agoMorningstar
View more